Fluidigm Expands Accessibility of Mass Cytometry and Imaging Mass Cytometry Technology with New Therapeutic Insights Services

Custom Projects and Consultation from Experimental Panel Design to Data Analysis             Providing Instrument Access Prior to Purchase Decision and Much‑Needed Capacity for Customers Affected by COVID-19 Related Laboratory Closures             New Collaboration via Therapeutic Insights Services Provides Visikol Customers Access to Rich Data and Powerful Analysis Tools from Imaging Mass Cytometry SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (Nasdaq:FLDM), [...]

AUM LifeTech and AUM BioTech Launch “Knockdown Coronavirus” Research Program

Philadelphia-based Initiative Will Facilitate SARS-CoV-2 Research to Develop Antiviral Therapy for COVID-19 Using RNA Silencing FANA ASO Technology PHILADELPHIA  -- The coronavirus pandemic has significantly disrupted life in most countries around the globe, causing a severe health and economic crisis. AUM LifeTech, Inc., a preclinical stage biotech company developing RNA therapeutics, and AUM BioTech, LLC, [...]

Scanning Capacitance Microscopy: Asylum Research Jupiter XR

Santa Barbara, CA -- Oxford Instruments Asylum Research is pleased to announce the release of a new Scanning Capacitance Microscopy (SCM) accessory for its Cypher and Jupiter XR atomic force microscopes (AFMs). SCM is a powerful imaging technique that can map electric charge carrier locations, types (p-type vs. n-type), and relative dopant concentration in semiconductors [...]

Danaher Corporation Announces CEO Transition

RAINER M. BLAIR TO SUCCEED THOMAS P. JOYCE, JR. AS PRESIDENT AND CEO IN SEPTEMBER 2020 WASHINGTON -- Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") today announced that Executive Vice President, Rainer M. Blair, will succeed Thomas P. Joyce Jr. as President and Chief Executive Officer and as a member of the Company's Board of Directors, upon Mr. [...]

Twist Bioscience Identifies Competitive Antibodies for SARS-CoV-2

– Functional Antibodies Identified to S1 Spike Protein and ACE2 Cellular Receptor – SOUTH SAN FRANCISCO, Calif.--Twist Bioscience Corporation (Nasdaq: TWST) today reported it has identified competitive antibodies to SARS-CoV-2, the virus that causes COVID-19, which could potentially be used for diagnostic tests or therapeutic treatments. Twist’s unique monoclonal antibody candidates bind with high affinity to [...]

U.S. FDA Renews Annual DILIsym Software Licenses

DILIsym Services, a Simulations Plus company, today announced that the FDA has renewed its annual multi-seat license for the DILIsym QST software. FDA Maintains Access to Leading Liver Injury Software Program DILIsym Services, Inc., a Simulations Plus company (Nasdaq: SLP) and a leading provider of simulation and modeling software for pharmaceutical safety and efficacy, today announced that [...]

Rapid COVID-19 Genome Sequencing Aids Outbreak Investigations

New Ion AmpliSeq SARS-CoV-2 Research Panel, now optimized for the Ion Torrent Genexus System*, assists with contact tracing to identify coronavirus hot spots CARLSBAD, Calif. -- As countries begin to ease restrictions and allow some businesses to reopen, contact tracing and epidemiological studies will be critical to understand resurgence of potential COVID-19 outbreaks. Scientists not only [...]

PerkinElmer Receives AOAC INTERNATIONAL First Action Official Methods of Analysis (OMA) Status for Solus One Salmonella Assay

Highest level of AOAC approval includes testing for foods such as romaine lettuce, raw salmon, dairy products and herbs and spices WALTHAM, Mass. – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced its Solus One™ Salmonella assay and methods have been granted First Action Official Methods of AnalysisSM (OMA) status, number 2020.03, [...]

ARRAYJET AT CUTTING EDGE OF COVID-19 ANTIBODY SCREENING TRIALS TO AID QUEST FOR VACCINE DEVELOPMENT

EDINBURGH – Arrayjet Limited, the Scottish-based bio-printing technology specialist for the life sciences industry, has re-purposed its in-house antibody screening technology to create a population-scale diagnostic programme that will help scientists better understand the behaviour of the Covid-19 virus and further the rapidity of a global vaccination programme. For this screening platform, an international collaborative [...]

Roswell Biotechnologies and Imec to Develop First Molecular Electronics Biosensor Chips for Infectious Disease Surveillance, Precision Medicine and DNA Storage

Technology Advances Rapid, Cost-effective DNA Sequencing on Portable Devices SAN DIEGO, Calif. and LEUVEN, BELGIUM -- Roswell Biotechnologies, Inc., the leader in molecular electronics sensor chips, and imec, a world-leading research and innovation hub in nanoelectronics and digital technologies,  announced today a partnership to develop the first commercially available molecular electronics biosensor chips. These chips are the brains [...]

Access IBO on Knowledge Center